EPH154 assessment of performance characteristics of covid-19 CIE-10-CM diagnosis code U07.1 using Sars-COV-2 nucleic acid amplification test results in the us fda best network

Objectives: To evaluate the performance characteristics of the ICD-10-CM diagnosis code, U07.1, in identifying COVID-19 cases in administrative claims data. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification test (NAAT) results in linked electronic health records...

Full description

Autores:

Moll, K
Hobbi, S
Zhou, CK
Fingar, K
Burrell, T
Hernandez-Medina, V
Alawar, N
Anderson, SA
Wong, HL
Obidi, J
Shoaibi, A

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/10720

Acceso en línea:

https://hdl.handle.net/11323/10720
https://repositorio.cuc.edu.co/

Palabra clave:

COVID
Sars-COV-2
ICD-10-CM
FDA
US

Rights

embargoedAccess

License

Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)